Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2000 Aug;1(2):97-102.
doi: 10.1007/s11934-000-0043-z.

The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia

G M Oades  1 , J D Eaton, R S Kirby
Affiliations
Review

The clinical role of alpha-blockers in the treatment of benign prostatic hyperplasia

G M Oades et al. Curr Urol Rep. 2000 Aug.

Abstract

Benign prostatic hyperplasia (BPH) is a highly prevalent condition that represents a significant health problem, which is likely to worsen as the population continues to age. alpha-1 adrenoceptor antagonists have been used in the treatment of this condition for well over 20 years and much is now known about their effects on the urinary tract. As these drugs have improved, their use as a first line treatment option in patients with lower urinary tract symptoms (LUTS), secondary to BPH, has continued to increase. This review details some of the background and rationale for the use of these drugs and, using the available information, compares their efficacy and tolerability profiles.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Urology. 1995 Mar;45(3):398-405 - PubMed
    1. Eur Urol. 1993;24(3):319-26 - PubMed
    1. Eur Urol. 1996;29(1):29-35 - PubMed
    1. Lancet. 1991 Aug 24;338(8765):469-71 - PubMed
    1. Br Med J. 1976 Nov 27;2(6047):1293-4 - PubMed

MeSH terms

LinkOut - more resources